INTRODUCTION AND OBJECTIVES: Many urologists are hesitant to offer surgical treatment for urinary incontinence in the genitourinary cancer survivor with significant comorbidities. We used the Charlson Comorbidity Index (CCI) and Frailty Index (FI) to investigate the relationship between preoperative comorbidity and immediate outcomes after artificial urinary sphincter (AUS) implantation. We hypothesized that even high-risk patients do well with this surgery.
METHODS: Using the National Surgical Quality Improvement Program (NSQIP), patients with CPT codes for AUS implantation were identified between 2007 and 2015. The patient's CCI was calculated based on ICD-9 codes. We calculated a FI score for each patient by adding the number of FI conditions the patient had, based on ICD-9 diagnoses. Complications were identified based on definitions in NSQIP and converted to Clavien-Dindo classification grades. Weighted descriptive statistics were calculated. Weighted multivariate logistic regression was used to examine the association between Grade I, Grade III, and overall complication and CCI, controlling for anesthesia type and race. We also used logistic regression to study the association between Grade I, Grade III, and overall complication and FI, controlling for age, anesthesia type, and race.
RESULTS: We reviewed data on 1370 patients. The mean age of patients was 70 AE 9.6 years old. 77% were Caucasian and the mean BMI was 29.6. 96% of patients had general anesthesia. The mean CCI was 4.0 AE 1.4. 47% of patients had only 1 FI condition whereas 25% had 2 or more FI conditions. For each post-operative complication recorded in NSQIP, less than 3% of the patients in this population exhibit any of these complications. Therefore, we only modeled Clavien-Dindo Grade I, III and overall complication. After adjusting for anesthesia and race, there were no association between having each of Grade I (OR [ CONCLUSIONS: AUS implantation is a safe procedure with low complication rates even in the patient with significant comorbidities.
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PD37-08 FOLEY PLACEMENT DOES NOT INFLUENCE URETHRAL MEASUREMENT FOR ARTIFICIAL URINARY SPHINCTER CUFF SIZING AT THE TIME OF SURGERY
Urszula Kowalik*, Durham, NC; Arman Kahokehr, Adelaide, Australia; Andrew Peterson, Durham, NC INTRODUCTION AND OBJECTIVES: Optimizing sizing of an artificial urinary sphincter (AUS) cuff is of paramount importance for technical success as well as quality of life (QOL) improvement in men with post-prostatectomy incontinence. Correct selection of the size of the artificial urinary sphincter cuff at the time of placement is dependent upon intraoperative measurement of the circumference of the urethra. Currently, there is no consensus on whether it is better to measure the urethra with or without a Foley catheter in place and it is unknown how this affects the chosen cuff size. We hypothesized that urethral circumferential measurement is not altered based on the presence or absence of a Foley catheter.
METHODS: We performed a retrospective review of prospectively collected data for purposes of institutional quality improvement. The prospective data was collected on consecutive first-time placement of a trans-perineal AUS from 2015 until 2018. Only men without a history of radiation and without a history of prior male sling or AUS were included. We performed a series of measurements during the procedure -without a catheter, with a 12Fr catheter and finally with a 16Fr catheter. The measurements were made using sterile umbilical tape cut to fit and a ruler. These were recorded, as was the final cuff size. Comparison was made between each measurement and the final cuff size.
RESULTS: Forty-seven patients were included in the analysis. As depicted in table 1, data was analyzed using a Spearman's coefficient revealing significant correlation between each measurement with
